Back

Risks and benefits of antiplatelet therapy in patients with abdominal aortic aneurysm without symptomatic atherosclerotic disease: a nationwide cohort study

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: The thoracoabdominal aorta in the spotlight: aneurysms, dissections, and their prognosis Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Chalotte Winther Nicolajsen

Viborg Hospital, Viborg (Denmark)

4 More presentations in this session

Presentation thumbnail
Male-female differences in the natural history of ascending thoracic aortic aneurysms: insights from the dissexion study
Mr M. Notenboom (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
The aortic root in young adults
Doctor N. Chatrath (London, GB)
Abstract Slides Video
Presentation thumbnail
Long-term clinical outcomes of EVAR within IFU compared to outside IFU
Doctor J. Kim (Incheon, KR)
Abstract Slides Video
Presentation thumbnail
The impact of endovascular aneurysm repair for ruptured abdominal aortic aneurysms: a single center experience.
Doctor Y. Kobayashi (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
The thoracoabdominal aorta in the spotlight: aneurysms, dissections, and their prognosis

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Temporal trends in antithrombotic therapy following transcatheter aortic valve implantation in denmark
thumbnail
Congress Presentation
Efficacy of beta blockers in patients with thoracic aortic aneurysm: meta-analysis of randomized controlled trials
thumbnail
Congress Session
The aorta and peripheral arteries: beyond the heart

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources